Andy Levine co-chairs Jones Day's global Private Equity Practice and has been the lead lawyer on global transactions for both sponsors and strategic participants, including ABM Industries, Bombardier, Brookfield, Cardinal Health, EagleTree Capital (f.k.a. Wasserstein & Co.), Monster Beverage, Omnicom Group, Pegasus Capital, Procter & Gamble, Ryder System, Sprint-Nextel, Stanley Works, Verizon, and WL Ross & Co.
Andy's recent transactions include Procter & Gamble's $4.2 billion acquisition of Merck KGaA's consumer health care business; EagleTree Capital's acquisitions of CORSAIR, Gaylord Chemical Company, and FuseFX and its recent sale of Paris Presents; Verizon's $3.6 billion sale of 24 data center sites to Equinix; Galenica's acquisition of Relypsa for $1.53 billion; Stillwater Mining's acquisition by Sibanye Gold for $2.2 billion; ITC Holdings' acquisition by Fortis for $11.3 billion; and ABM's acquisition of GCA Services for $1.25 billion. He has substantial experience in venture capital, distress M&A, joint ventures, special committee transactions, corporate governance, takeover preparedness, and restructurings. Andy has worked in a wide range of industries, including pharmaceuticals and health care, consumer goods and retail, telecommunications, real estate, financial services, facility services, shipping, advertising and marketing, energy, and manufacturing.
Andy is a frequent author on Delaware law developments, private equity, M&A, and governance issues and has appeared as a commentator on CNBC's Squawk Box, Bloomberg TV, and Bloomberg Radio.
Delaware Court of Chancery Invalidates For-Cause Removal Requirement for Unclassified Boards of Directors
Things Are Looking Up: The Outlook for M&A Transactions in 2014, coauthor, Mergers and Acquisitions Law 2014
Confidence, Risk, and Reason for Optimism: A Look Ahead at M&A in 2013, coauthor, Mergers and Acquisitions Law 2013
Revisiting the Legal Due Diligence Paradigm, coauthor, Inside the Minds: Business Due Diligence Strategies, 2012 ed.
- March 2004
Truth and Confidentiality, coauthor, The Daily Deal, Corporate Dealmakers Section
- May 2003
Omnicare, coauthor, New York Law Journal
- June 3, 2013
2013 Deutsche Bank M&A Forum
- Boston University (J.D. magna cum laude 1998; Law Review); Northwestern University (B.A. 1994)
- New York
Two-time Private Equity MVP (2016 and 2017) — Law360
40 Under 40 Recognition Award recipient — The M&A Advisor
Editorial board member (PE) — Law360 (2018-2019)
Editorial board member (M&A) — Law360 (2013-2016)
The Legal 500 US — M&A: Large Deals ($1 billion+) and Private Equity